Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

This infectious respiratory illness is on the rise, especially among children. Here's what parents need to know.

Former Malaysian Prime Minister Mahathir Mohamad has been admitted to hospital for a respiratory infection, his office said ...

Using cutting-edge breath sampling, scientists have achieved a breakthrough in diagnosing lower respiratory tract infections with an in vitro assay that could transform patient care in ICUs worldwide.

Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...

A mother’s worst nightmare is watching her child fall gravely ill, feeling helpless as the condition becomes worse. When ...

The RSV vaccine Abrysvo was highly effective against hospital and ED encounters in a large cohort of older adults with comorbidities and immunocompromising conditions.

All adults aged 50 and older should receive a vaccine against bacteria that can cause pneumonia and meningitis, federal ...

(Corrects headline, paragraph 1 and 2 in Oct. 17 story to show the drug reduced medically attended lower respiratory ...

Clesrovimab is an extended half-life RSV neutralizing antibody in development for all infants in their first RSV season and ...

Malaysia's nearly 100-year-old former prime minister Mahathir Mohamad has been hospitalised for a respiratory infection, his ...

Merck’s (NYSE:MRK) monoclonal antibody clesrovimab, designed as a prophylactic against respiratory syncytial virus (RSV), has ...